Home
Product
Human medicine
Veterinary drug active pharmaceutical ingredients
Nutritional supplements
About Us
Company Overview
Honorary Qualifications
Corporate Culture
Blog
Company News
Industry News
Join Us
Job Recruitment Notice
Employment Philosophy
Contact us
Online Consultation
Oct 08,2025
View details
Against the backdrop of the global pharmaceutical industry shifting toward innovation-driven growth, increasingly stringent environmental regulations, and the rapid restructuring of supply chains, pharmaceutical intermediates—acting as the critical link between basic chemical production and active pharmaceutical ingredient manufacturing—are undergoing a transformative shift in their development paradigm. No longer focused solely on scaling up, the industry is now prioritizing quality, efficiency, and technological breakthroughs. From process innovations to reshaping market dynamics, and from policy guidance to global expansion strategies, the pharmaceutical intermediate sector is entering a new phase of development characterized by high-end sophistication, sustainability, and intelligent manufacturing. The next five years are poised to become a pivotal window for redefining industry value, driving significant advancements across the board.
Oct 06,2025
The quality indicators of intermediates directly determine the final quality of the drug. Within the industry, strict testing standards are typically set for intermediates: purity must exceed 99.5% (as determined by HPLC analysis), the enantiomeric excess (ee value) of chiral isomers must be no less than 99% (via Chiral HPLC testing), and residual solvent levels must be kept below 0.05% (using GC-MS analysis).
Oct 28,2025
The synthesis of complex drugs often requires multiple sequential reactions, and the involvement of intermediates can break down the lengthy process into modular units, significantly shortening the reaction timeline. Take the antihypertensive drug "Losartan" as an example: by using the key intermediate 2-n-butyl-4-chloro-5-formylimidazole, the total number of reaction steps can be reduced by 30%, dramatically easing the synthesis process.
In the complex ecosystem of the pharmaceutical industry, pharmaceutical intermediates serve as the pivotal compounds that bridge basic chemical raw materials and active pharmaceutical ingredients (APIs). Although they typically lack direct medicinal value themselves, intermediates play an indispensable role throughout the entire chain—from drug development and manufacturing to quality assurance.